Table 22Summary of included studies for inpatient versus outpatient subgroup analysis for comparison 3e Mirtazapine versus TCAs

StudyPopulationInterventionComparisonComments
Inpatient setting (K=2, N=425)

Richou 1995

RCT

France

Inpatient

N=174

Baseline severity: More severe

Mean age (years): 50.7

Sex (% female): 67

Ethnicity (% BME): NR

Mirtazapine 20-80mg/dayClomipramine 50-200mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

Zivkov 1995

RCT

Former Yugoslavia

Inpatient

N=251

Baseline severity: More severe

Mean age (years): 46.9

Sex (% female): 78

Ethnicity (% BME): NR

Mirtazapine 20-60mg/dayAmitriptyline 75-225mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

Outpatient setting (K=4, N=387)

Bremner 1995a

RCT

US

Outpatient

N=100

Baseline severity: More severe

Mean age (years): 39.0

Sex (% female): 67

Ethnicity (% BME): NR

Mirtazapine 5-35mg/dayAmitriptyline 40-280mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

MIR 003-020 (FDA)a

RCT

US

Outpatient

N=87

Baseline severity: More severe

Mean age (years): 43.5

Sex (% female): 45

Ethnicity (% BME): NR

Mirtazapine 5-35mg/dayAmitriptyline 40-280mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

MIR 003-021 (FDA)a

RCT

US

Outpatient

N=100

Baseline severity: More severe

Mean age (years): 44.5

Sex (% female): 55

Ethnicity (% BME): NR

Mirtazapine 5-35mg/dayAmitriptyline 40-280mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

Smith 1990a

RCT

US

Outpatient

N=100

Baseline severity: More severe

Mean age (years): NR

Sex (% female): NR

Ethnicity (% BME): NR

Mirtazapine 10-35mg/dayAmitriptyline 80-280mg/day

Treatment duration (weeks): 6

Outcome (for inpatient versus outpatient subgroup analysis):

  • Response

a

Three-armed trial but where possible the demographics reported here are for only the two relevant arms.

BME: black, minority, ethnic; mg: milligrams; N: number of participants; NR: not reported; RCT: randomised controlled trial.

From: Service delivery Models and settings for delivery of services

Cover of Service delivery Models and settings for delivery of services
Service delivery Models and settings for delivery of services: Depression in adults: Evidence review A.
NICE Guideline, No. 222.
Copyright © NICE 2022.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.